bioRxivMolecular BiologyPreprint
Comparative characterization of Cas12a2 orthologs identifies high-activity nucleases for programmable cell elimination
Anna Singer, Emma January, Erin K. ZessiD, Allison J.N. Antonakos, Matthew B. BegemanniD
- Citations
- 0
Abstract
Cas12a2 CRISPR nucleases, including SuCas12a2, have been shown to have extensive collateral activity towards RNA, ssDNA, and dsDNA. This collateral activity results in targeted cell elimination and has applications across biotechnology, agriculture, and human health. We explored the natural genetic diversity of Cas12a2 nucleases and characterized nine novel orthologs in a DNA damage kinetic assay in E. coli. Three new Cas12a2 orthologs (RsCas12a2, SdCas12a2, and HmCas12a2) were shown to have high collateral activity towards DNA. These nucleases are highly divergent from SuCas12a2, have conserved core RuvC catalytic residues, and have sequence diversity in the previously reported aromatic clamp residues required for nucleic acid positioning in the active site. We defined PFS preferences and mismatch tolerance for each high-activity Cas12a2 nuclease, expanding the available Cas12a2 toolbox, and discovered functional differences with obvious impacts on downstream applications.
- organism: E. coli
- assay: CRISPR screen
- research focus: benchmarking
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Target RNA-triggered CRISPR-Cas12a2 Preferentially Cleaves Collateral DNA over RNA
Sobita Kunwar, Thomson Hallmark, … Ryan N. Jackson·Nucleic Acids ResearchPeer-reviewed·May 28, 2026
- Pervasive off-target and double-stranded DNA nicking by CRISPR-Cas12a
K. Murugan, A. Seetharam, … D. G. Sashital·bioRxiv·Jun 2, 2019
- CRISPR-Cas12a REC2 - NUC interactions drive target-strand cleavage and constrain trans cleavage.
Anthony Newman, Aakash Saha, … Gaétan Burgio·Nucleic Acids ResearchPeer-reviewed·Sep 23, 2025
- Cas12a trans-cleavage can be modulated in vitro and is active on ssDNA, dsDNA, and RNA
Ryan T. Fuchs, Jennifer L. Curcuru, … G. Brett Robb·bioRxiv·Apr 8, 2019
- Nuc domain electrostatics drive the trans cleavage activity of CRISPR-Cas12a
Anthony Newman, Lora M. Starrs, Gaétan Burgio·Nucleic Acids ResearchPeer-reviewed·Dec 18, 2025
- Large-scale structural rearrangements unleash indiscriminate nuclease activity of CRISPR-Cas12a2
J. P. Bravo, T. Hallmark, … D. W. Taylor·bioRxiv·Jun 13, 2022